Life & Brain

Life & Brain

Bonn, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Life & Brain is a private, revenue-generating service and product company in the genetics and genomics sector. Its core business model revolves around providing comprehensive omics analysis services (e.g., NGS, methylation profiling, proteomics) and developing specialized iPSC-derived cellular models, particularly for neurological and neuroimmunological applications like its LB:MiG microglia. The company leverages its unique academic proximity in Bonn to drive R&D, holds several technology provider certifications, and participates in European research consortia, positioning it as a specialized partner for both academic and industrial clients in the life sciences.

NeuroscienceNeuroimmunology

Technology Platform

Integrated omics analysis services (genomics, epigenomics, proteomics) combined with a proprietary iPSC platform for generating specialized cellular models, particularly for the central nervous system. Features AI-based phenotypic analysis (PhenoMiG) for microglia and holds certified provider status for multiple leading technologies (Twist, Olink, Seer).

Opportunities

The growing demand for integrated multi-omics data and human-relevant cellular models in drug discovery presents a significant expansion opportunity.
Specialization in high-need areas like neuroimmunology with proprietary cells (LB:MiG) and AI-phenotyping allows the company to capture premium value and differentiate from generic service providers.

Risk Factors

Intense competition in the omics service market could pressure pricing and margins.
The company faces technology obsolescence risk, requiring constant R&D investment.
Reliance on key academic partnerships for innovation introduces a degree of strategic dependency.

Competitive Landscape

Life & Brain competes with large, global contract research organizations (CROs) offering omics services and with other specialized iPSC cell providers. Its differentiation lies in its deep academic integration in neuroscience, its combined omics+cellomics offering, and its focus on complex, AI-enhanced phenotypic assays for niche applications like microglia biology.